🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Drug-induced Liver Injury: Itching Study

Recruitingn/aAges 18 Years - anyAllUniversity of Nottingham
NCT06446609 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Idiosyncratic drug-induced liver injury (DILI) is an unpredictable adverse hepatic reaction to a medication used in its therapeutic dose. DILI is the second most common cause of itching in adult Hepatology after biliary obstruction. In particular cholestatic or mixed pattern types of DILI (in which bile flow from the liver is impaired) are associated with long-lasting effects as well as reduced quality of life. There is therefore an urgent need to determine the incidence and natural history of itching in DILI and establish a network of centres that will form a basis for a clinical trial to investigate a novel intervention to treat these.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 (no upper age limit) and able to give informed written consent * Exposure to potential causal agent and diagnosed with suspected acute DILI defined as meeting one of the following analytical thresholds at enrolment (visit 1): * alanine transaminase (ALT) ≥5 times upper limit of normal (ULN) or * alkaline phosphatase ≥2 times ULN or * ALT ≥3 times ULN plus total bilirubin \>2 times ULN Results from clinical test samples collected within 36h of visit will be acceptable (as DILI is an acute event, patients are expected to recover or deteriorate quickly so enrolment aligned with diagnostic tests is necessary). Exclusion Criteria: * Patients with comorbidities of eczema and urticaria associated with pruritus * Patients with existing diagnosis of blood-borne viral hepatitis infection (Hepatitis B/C/E)
💊

What it tests

  • Not listed
📍

Where

1 site
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy